• HOME
  • MARKETS
  • ANALYSIS
  • SIGN UP
No Result
View All Result
FTD Limited
  • HOME
  • MARKETS
  • ANALYSIS
  • SIGN UP
No Result
View All Result
FTD Limited
No Result
View All Result

Friday, November 27, 2020 Headlines

Burc Oran by Burc Oran
November 27, 2020
Reading Time: 5 mins read
A A
Trump's Defense Veto; Ant Group; UK's free trade deal with Turkey
0
SHARES
46
VIEWS
tweetpostshare
Share us on social media
  1. Confession from AstraZeneca about vaccine
  2. Europe’s trial to solve its trade problems with Biden
  3. President Trump’s statements to the journalists

Embed from Getty Images

Confession from AstraZeneca About Vaccine

There are ongoing trust debates regarding the vaccine, which was developed by AstraZeneca and Oxford University. The vaccine developed by AstraZeneca and Oxford University was announced with the slogan “Get yourself a vaccine”, pointing out that it is cheaper than a cup of coffee.

According to the New York Times, Astrazeneca using the phrase ‘up to 90%’ when announcing the vaccine, the lack of some information about the vaccine in the statement, and the questions why the first vaccine was administered half a dose aroused.

Many scientists and industry experts highlighted that AstraZeneca’s initial shortcomings in the way the data were disclosed, the way the vaccine was administered, eroded their confidence in the reliability of the results.

AstraZeneca has sparked controversy, admitting that there was a significant mistake in the vaccine dosage received by some participants, since the New York Times released preliminary results that were reported to be 90% effective.

Many scientists and industry experts highlighted that AstraZeneca’s initial lack of explanation of the data, many mistakes such as the way the vaccine was administered, undermined their confidence in the reliability of the results.

In particular, US officials underlined that the results, which are announced as 90% effective, do not reflect the data of the elderly, and that the results are not clear.

Authorities said this made it less likely that the US or other countries’ approval authorities would quickly grant the AstraZeneca – University of Oxford vaccine emergency use, and this was a glitch.

AstraZeneca’s director of research and development, Menelas Pangalos stated that:

‘’ The error in the dosage was made by an employee, he was notified immediately when detected, and he signed a plan to continue testing the vaccine at different doses.’’

However, Natalie Dean, a biostatistician at the University of Florida, said that “they got a poor grade in terms of transparency and rigor in their reported results.”

Embed from Getty Images

Europe’s Trial to Solve its Trade Problems with Biden

By approaching president-elect Joe Biden’s team early on, France and Germany are seeking to normalize trading relationships between the European Union and the United States.

France and Germany are preparing to contact Joe Biden’s team to resolve trade issues between the US and Europe.

The most important agenda for France is to solve the $12 billion customs duty on products between the two countries due to the aircraft production dispute, while Germany wants to restart free trade negotiations.

Johann Wadephul, foreign policy expert and vice-chair of the committee at Chancellor Merkel’s party, stated that:

“We are ready to start the conversations as quickly as possible. “

Then French Finance Minister Bruno Le Maire said, “I hope that the Biden administration can offer a new beginning for the relations between Europe and the USA.”

The most important issue where Germany, France, and Europe are united is the removal of the Trump administration’s tariffs on European steel and aluminum, new tax regulations for digital transnational companies, and a reform of the World Trade Organization.

Embed from Getty Images

President Trump’s Statements to the Journalists

After the video conference held with the American soldiers who were serving abroad, President Trump made a few statements to the journalists for the first time. He announced that if the Electoral College finalized the presidency of Joe Biden it would be a wrong step, but he would still leave the White House.

Referring to the second-round election in Georgia that will determine whether the Senate will be controlled by Republicans or Democrats, Trump announced that he will probably hold a rally for Republican senator candidates in Georgia on Saturday.

Repeating the claims that the Democrats cheated the elections and that they were the real winner, Trump said,

 “One thing I know is that Joe Biden didn’t actually get 80 million votes. Also, Biden didn’t break Barack Obama’s black vote record.”

Trump was asked whether he will leave office if Biden got approved as the winner. He answered in the following way:

“It is difficult to accept the election results because there is a large-scale irregularity. If the Electoral Council approves the presidency of Biden, which of course will be a mistake, I will leave the White House. You know that.’’

Learn more about us

Şununla paylaş:

  • Facebook
  • X (Twitter)
  • LinkedIn
  • Daha fazla
Tags: AstrazenecaDonald TrumpEuropeJoe Bidentrade deals
TweetShareShareSend
Previous Post

Silver is Testing The Middle Point of the Bearish Trend

Next Post

GBPUSD Spot and Options Markets Divergence is Accelerating

Related Posts

S&P 500 Enjoys CPI Rally Despite Hawkish FOMC Dot plot 
Home

S&P 500 Enjoys CPI Rally Despite Hawkish FOMC Dot plot 

COT Weekly Non-Commercial Net Positions
DAILY UPDATES

COT Weekly Non-Commercial Net Positions

Gold Caught Between the Short-Term Uptrend and Long-Term Key Resistance
DAILY UPDATES

Gold Caught Between the Short-Term Uptrend and Long-Term Key Resistance

COT Weekly Non-Commercial Net Positions
DAILY UPDATES

COT Weekly Non-Commercial Net Positions

Monthly Market Outlook
ANALYSIS

Monthly Market Outlook

COT Weekly Non-Commercial Net Positions
DAILY UPDATES

COT Weekly Non-Commercial Net Positions

Next Post
GBPUSD Spot and Options Markets Divergence is Accelerating

GBPUSD Spot and Options Markets Divergence is Accelerating

You might also like

What is MACD and How to Use it Effectively?

What is MACD and How to Use it Effectively?

Unveiling the Tapestry of Trading: Insights into Market Participants

Unveiling the Tapestry of Trading: Insights into Market Participants

Dynamics of Fiscal and Monetary Policies in Multi-Asset Strategy

Dynamics of Fiscal and Monetary Policies in Multi-Asset Strategy

Bitcoin Holds onto Key Support After Last Week’s Plunge

Bitcoin Holds onto Key Support After Last Week’s Plunge

Beyond the Technical: The Power of Trading Psychology

Beyond the Technical: The Power of Trading Psychology

How to Know When You’re Ready to Switch to Live Trading?

How to Know When You’re Ready to Switch to Live Trading?

Recent Posts

  • COT Weekly Non-Commercial Net Positions
  • EURUSD Under Heavy Pressure from Long-Term Resistance and Bearish Formation 
  • Silver Forms Double Top, Testing Key Support for Potential Downward Move 
  • Monthly Market Outlook
  • COT Weekly Non-Commercial Net Positions
FTD Limited

The content of the site is presented for informational purposes only not to give any investment advice which mainly focuses on financial instruments such as Forex, Spot Metals, CFDs, and Indices.

MENU

  • HOME
  • MARKETS
  • ANALYSIS
  • SIGN UP

Latest Articles

  • COT Weekly Non-Commercial Net Positions
  • EURUSD Under Heavy Pressure from Long-Term Resistance and Bearish Formation 
  • Silver Forms Double Top, Testing Key Support for Potential Downward Move 

Subscribe to our newsletter and get notified about the next update.

    © 2021 FTD Limited

    FTD Articles is a website prepared by FTD Limited's research team. FTD Limited is an online brokerage company offering products of Forex, Spot Metals and CFDs.

    The ideas and the information shown here have no responsibility of any of the trading decisions made by the investors or the visitors of this site. Therefore, under no circumstances will FTD Limited nor FTD Articles be held responsible or liable in any way for any claims, damages, losses, costs or liabilities resulting or arising directly or indirectly from the use of website content. We recommend that you seek advice if you have not involved with trading before in order to prevent potential risks that may arise.

    No Result
    View All Result
    • HOME
    • MARKETS
    • ANALYSIS
    • SIGN UP

    © 2021 FTD Limited

    FTD Articles is a website prepared by FTD Limited's research team. FTD Limited is an online brokerage company offering products of Forex, Spot Metals and CFDs.

    The ideas and the information shown here have no responsibility of any of the trading decisions made by the investors or the visitors of this site. Therefore, under no circumstances will FTD Limited nor FTD Articles be held responsible or liable in any way for any claims, damages, losses, costs or liabilities resulting or arising directly or indirectly from the use of website content. We recommend that you seek advice if you have not involved with trading before in order to prevent potential risks that may arise.

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In
    This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
    • Facebook
    • X (Twitter)
    • LinkedIn
    • More Networks
    Share via
    Facebook
    X (Twitter)
    LinkedIn
    Mix
    Email
    Print
    Copy Link
    Copy link
    CopyCopied